-
Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review
Mar 10, 2025, 14:00 PM -
Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil
Mar 10, 2025, 14:00 PM -
Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Mar 10, 2025, 14:00 PM -
Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies
Mar 10, 2025, 14:00 PM -
Open-Source LLMs Performance on Information Retrieval Tasks for Health Outcomes Research
Mar 10, 2025, 14:00 PM -
Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China
Mar 10, 2025, 14:00 PM -
Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness
Mar 10, 2025, 14:00 PM -
Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards
Mar 10, 2025, 14:00 PM -
Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time
Mar 10, 2025, 14:00 PM -
Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies
Mar 10, 2025, 14:00 PM -
Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review
Mar 10, 2025, 14:00 PM -
Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab
Mar 10, 2025, 14:00 PM -
Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study
Mar 10, 2025, 14:00 PM -
Assessing Differences in Clinical Burden Across Payers for Non-Obstructive Hypertrophic Cardiomyopathy
Mar 10, 2025, 14:00 PM -
Benchmarking Duration of Injectable Medication Use: How do Claim Intervals Compare with Days Supply in the Real World?
Mar 10, 2025, 14:00 PM -
Developing a Value Assessment Framework for Modified New Drugs In China
Mar 10, 2025, 14:00 PM
